Viewing Study NCT06633523



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06633523
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-27

Brief Title: Optimized Posterior Left Atrial Wall Ablation Strategy for PeAF
Sponsor: None
Organization: None

Study Overview

Official Title: Optimized Posterior Left Atrial Wall Ablation Strategy for Persistent Atrial Fibrillation A Multicenter Large-Sample Clinical Study
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is an open-label multicenter randomized parallel-controlled clinical trial The study aims to investigate the optimal ablation method for the posterior left atrial wall in patients with persistent atrial fibrillation PsAF
Detailed Description: This is an open-label multicenter randomized parallel-controlled clinical trial The study aims to investigate the optimal ablation method for the posterior left atrial wall in patients with persistent atrial fibrillation PsAF

The main content of the research includes comparing three approaches through randomization pulmonary vein isolation PVI alone PVI plus pulse field ablation PWI and PVI plus anatomical and potential-guided ablation to evaluate their effects on reducing the recurrence rate of atrial fibrillation The study is designed with three groups the PVI-alone group the PVI PWI group and the PVI plus anatomical and potential-guided ablation group

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None